Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Thermo, Lilly In Supply-Chain Deal

by Marc S. Reisch
April 5, 2010 | A version of this story appeared in Volume 88, Issue 14

Thermo Fisher Scientific and Eli Lilly & Co. have expanded a clinical-trial-materials supply agreement. Lilly says the deal will reduce the cost of drug development and speed delivery of innovative medicines to patients. Under the terms of a new five-year agreement, by summer, Fisher Clinical Services will take over responsibility for Lilly's in-house clinical-trial-materials manufacturing, packing, and labeling operation at Lilly Technology Center North, in Indianapolis. By the end of the year, Fisher will handle distribution of clinical-trial materials for Lilly throughout North America. As part of the deal, Fisher will buy Lilly manufacturing equipment.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.